TomoTherapy has entered into a memorandum of understanding to acquire certain assets of Hi-Art relating to the sales and service of TomoTherapy's products in Japan.
Subscribe to our email newsletter
Over the next several weeks, TomoTherapy and Hi-Art will negotiate a definitive purchase agreement. The transaction is expected to close in the fourth quarter of 2008, at which time the current distribution agreement will cease.
Fred Robertson, CEO of TomoTherapy, said: “As TomoTherapy grows, we continue to assess how we can best serve our customers in all markets. This move in Japan reflects our commitment to our current and future Japanese customers.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.